Company News and Media Resources
News Releases
January, 25, 2021
Frontiers in Bioengineering and Biotechnology: Natural Vascular Scafolding Treatment PromotesOutward Remodeling during Arteriovenous Fistula Development in Rats. View
January 2021
MedTech Strategist: Alucent Biomedical: Re-Envisioning PAD Treatment with a Natural Vascular Scaffold. View
December 8, 2020
Stanford Surgeon Venita Chandra Joins Alucent Biomedical Scientific Advisory Board as Company Enters Arteriovenous Fistula Market View
October 1, 2020
Alucent Biomedical Announces $35 Million Series B Financing Press Release
May 27, 2020
Alucent Biomedical Announces First Patient Enrolled in Phase 1 Natural Vascular Scaffolding Clinical Trial View
January 9, 2020
Alucent Biomedical Announces FDA Approval to Proceed with Natural Vascular Scaffolding Clinical Trial View
September 25, 2018
Alucent Biomedical Announces Formation of Scientific Advisory Board View
Scientific and Clinical Presentations
Vascular Cures: Innovation spotlight – “Can We Make Stents Obsolete?” View
ACS 2020: Novel Sample Preparation Technique for Testing Biological Tissue via Differential Scanning Calorimetry Poster
ACS 2020: Photosensitized Tyrosine Dimerization Poster
MedTech Summit 2020 presentation:
JCTR 2020: Retained Functionality of Atherosclerotic Human Arteries Following Photoactivated Linking of Extracellular Matrix by Natural Vascular Scaffolding Treatment Read Article
ISET 2020: Natural Vascular Scaffolding for Treatment of Femoropopliteal Lesions in Peripheral Arterial Disease Poster
CRT 2020: Natural Vascular Scaffolding Promotes Post-Femoropopliteal PTA Patency Without Stent Implantation Abstract
Proud to be part of the nations fastest growing Life Sciences Community.
By embracing diversity and collaboration, BioHive has become the fastest-growing life science community in America. And our innovations are improving the lives of millions of patients.
Learn More